Executive Development Programme in Drug Pricing and Value Creation

-- ViewingNow

The Executive Development Programme in Drug Pricing and Value Creation is a certificate course designed to empower professionals with the essential skills needed to navigate the complex landscape of pharmaceutical pricing and value creation. This programme is critical for those who wish to stay competitive in the industry, as it addresses the growing demand for professionals who can effectively price drugs and demonstrate their value to stakeholders.

4.5
Based on 7,200 reviews

4,849+

Students enrolled

GBP £ 140

GBP £ 202

Save 44% with our special offer

Start Now

ๅ…ณไบŽ่ฟ™้—จ่ฏพ็จ‹

Through this course, learners will gain a comprehensive understanding of the drug pricing process, including regulatory requirements, cost drivers, and pricing strategies. They will also develop the ability to evaluate the economic and clinical value of drugs and communicate this value to payers, providers, and patients. By completing this programme, learners will be equipped with the skills and knowledge necessary to advance their careers in the pharmaceutical industry and make a positive impact on healthcare outcomes.

100%ๅœจ็บฟ

้šๆ—ถ้šๅœฐๅญฆไน 

ๅฏๅˆ†ไบซ็š„่ฏไนฆ

ๆทปๅŠ ๅˆฐๆ‚จ็š„LinkedInไธชไบบ่ต„ๆ–™

2ไธชๆœˆๅฎŒๆˆ

ๆฏๅ‘จ2-3ๅฐๆ—ถ

้šๆ—ถๅผ€ๅง‹

ๆ— ็ญ‰ๅพ…ๆœŸ

่ฏพ็จ‹่ฏฆๆƒ…

โ€ข Introduction to Drug Pricing and Value Creation
โ€ข Understanding Pharmaceutical Markets and Pricing Dynamics
โ€ข Regulatory Frameworks for Drug Pricing
โ€ข Pricing Strategies for Pharmaceutical Products
โ€ข Health Economics and Pharmacoeconomics
โ€ข Value Assessment in Drug Pricing
โ€ข Drug Development and Life Cycle Management
โ€ข Global Drug Pricing Trends and Case Studies
โ€ข Stakeholder Engagement and Negotiations in Drug Pricing
โ€ข Ethical Considerations in Drug Pricing and Value Creation

่Œไธš้“่ทฏ

The Executive Development Programme in Drug Pricing and Value Creation focuses on the growing demand for professionals skilled in drug pricing and value creation in the UK. As pharmaceutical companies and healthcare providers navigate complex drug pricing landscapes, employees with expertise in this field are increasingly sought after. This 3D pie chart demonstrates the distribution of job market trends in this sector, with the following roles highlighted: 1. **Pharmacoeconomist**: Representing 35% of the job market, pharmacoeconomists assess the cost-effectiveness of medications and other healthcare interventions. They play a critical role in determining drug pricing and overall healthcare resource allocation. 2. **Health Economist**: With a 25% share, health economists study the economic impact of healthcare policies and treatments. They contribute to drug pricing decisions by evaluating the financial implications of pharmaceutical products on healthcare systems and patients. 3. **Pharmaceutical Pricing Analyst**: Accounting for 20% of the demand, pharmaceutical pricing analysts specialize in analyzing market trends and competitors' pricing strategies. They assist in setting and justifying drug prices and collaborate with cross-functional teams to optimize product value propositions. 4. **Market Access Manager**: A 15% share is held by market access managers, who facilitate the entry and reimbursement of pharmaceutical products in healthcare systems. They bridge the gap between pharmaceutical companies and payers, ensuring patient access and optimizing product value. 5. **Drug Pricing Consultant**: Making up the remaining 5%, drug pricing consultants provide strategic guidance and insights to pharmaceutical companies and healthcare organizations. They address challenges related to drug pricing, market access, and reimbursement, helping clients maximize the value of their products.

ๅ…ฅๅญฆ่ฆๆฑ‚

  • ๅฏนไธป้ข˜็š„ๅŸบๆœฌ็†่งฃ
  • ่‹ฑ่ฏญ่ฏญ่จ€่ƒฝๅŠ›
  • ่ฎก็ฎ—ๆœบๅ’Œไบ’่”็ฝ‘่ฎฟ้—ฎ
  • ๅŸบๆœฌ่ฎก็ฎ—ๆœบๆŠ€่ƒฝ
  • ๅฎŒๆˆ่ฏพ็จ‹็š„ๅฅ‰็Œฎ็ฒพ็ฅž

ๆ— ้œ€ไบ‹ๅ…ˆ็š„ๆญฃๅผ่ต„ๆ ผใ€‚่ฏพ็จ‹่ฎพ่ฎกๆณจ้‡ๅฏ่ฎฟ้—ฎๆ€งใ€‚

่ฏพ็จ‹็Šถๆ€

ๆœฌ่ฏพ็จ‹ไธบ่Œไธšๅ‘ๅฑ•ๆไพ›ๅฎž็”จ็š„็Ÿฅ่ฏ†ๅ’ŒๆŠ€่ƒฝใ€‚ๅฎƒๆ˜ฏ๏ผš

  • ๆœช็ป่ฎคๅฏๆœบๆž„่ฎค่ฏ
  • ๆœช็ปๆŽˆๆƒๆœบๆž„็›‘็ฎก
  • ๅฏนๆญฃๅผ่ต„ๆ ผ็š„่กฅๅ……

ๆˆๅŠŸๅฎŒๆˆ่ฏพ็จ‹ๅŽ๏ผŒๆ‚จๅฐ†่Žทๅพ—็ป“ไธš่ฏไนฆใ€‚

ไธบไป€ไนˆไบบไปฌ้€‰ๆ‹ฉๆˆ‘ไปฌไฝœไธบ่Œไธšๅ‘ๅฑ•

ๆญฃๅœจๅŠ ่ฝฝ่ฏ„่ฎบ...

ๅธธ่ง้—ฎ้ข˜

ๆ˜ฏไป€ไนˆ่ฎฉ่ฟ™้—จ่ฏพ็จ‹ไธŽๅ…ถไป–่ฏพ็จ‹ไธๅŒ๏ผŸ

▼

ๅฎŒๆˆ่ฏพ็จ‹้œ€่ฆๅคš้•ฟๆ—ถ้—ด๏ผŸ

▼

WhatSupportWillIReceive

▼

IsCertificateRecognized

▼

WhatCareerOpportunities

▼

ๆˆ‘ไป€ไนˆๆ—ถๅ€™ๅฏไปฅๅผ€ๅง‹่ฏพ็จ‹๏ผŸ

▼

่ฏพ็จ‹ๆ ผๅผๅ’Œๅญฆไน ๆ–นๆณ•ๆ˜ฏไป€ไนˆ๏ผŸ

▼

่ฏพ็จ‹่ดน็”จ

ๆœ€ๅ—ๆฌข่ฟŽ
ๅฟซ้€Ÿ้€š้“๏ผš GBP £140
1ไธชๆœˆๅ†…ๅฎŒๆˆ
ๅŠ ้€Ÿๅญฆไน ่ทฏๅพ„
  • ๆฏๅ‘จ3-4ๅฐๆ—ถ
  • ๆๅ‰่ฏไนฆไบคไป˜
  • ๅผ€ๆ”พๆณจๅ†Œ - ้šๆ—ถๅผ€ๅง‹
Start Now
ๆ ‡ๅ‡†ๆจกๅผ๏ผš GBP £90
2ไธชๆœˆๅ†…ๅฎŒๆˆ
็ตๆดปๅญฆไน ่Š‚ๅฅ
  • ๆฏๅ‘จ2-3ๅฐๆ—ถ
  • ๅธธ่ง„่ฏไนฆไบคไป˜
  • ๅผ€ๆ”พๆณจๅ†Œ - ้šๆ—ถๅผ€ๅง‹
Start Now
ไธคไธช่ฎกๅˆ’้ƒฝๅŒ…ๅซ็š„ๅ†…ๅฎน๏ผš
  • ๅฎŒๆ•ด่ฏพ็จ‹่ฎฟ้—ฎ
  • ๆ•ฐๅญ—่ฏไนฆ
  • ่ฏพ็จ‹ๆๆ–™
ๅ…จๅŒ…ๅฎšไปท โ€ข ๆ— ้š่—่ดน็”จๆˆ–้ขๅค–่ดน็”จ

่Žทๅ–่ฏพ็จ‹ไฟกๆฏ

ๆˆ‘ไปฌๅฐ†ๅ‘ๆ‚จๅ‘้€่ฏฆ็ป†็š„่ฏพ็จ‹ไฟกๆฏ

ไปฅๅ…ฌๅธ่บซไปฝไป˜ๆฌพ

ไธบๆ‚จ็š„ๅ…ฌๅธ็”ณ่ฏทๅ‘็ฅจไปฅๆ”ฏไป˜ๆญค่ฏพ็จ‹่ดน็”จใ€‚

้€š่ฟ‡ๅ‘็ฅจไป˜ๆฌพ

่Žทๅพ—่Œไธš่ฏไนฆ

็คบไพ‹่ฏไนฆ่ƒŒๆ™ฏ
EXECUTIVE DEVELOPMENT PROGRAMME IN DRUG PRICING AND VALUE CREATION
ๆŽˆไบˆ็ป™
ๅญฆไน ่€…ๅง“ๅ
ๅทฒๅฎŒๆˆ่ฏพ็จ‹็š„ไบบ
London School of International Business (LSIB)
ๆŽˆไบˆๆ—ฅๆœŸ
05 May 2025
ๅŒบๅ—้“พID๏ผš s-1-a-2-m-3-p-4-l-5-e
ๅฐ†ๆญค่ฏไนฆๆทปๅŠ ๅˆฐๆ‚จ็š„LinkedInไธชไบบ่ต„ๆ–™ใ€็ฎ€ๅŽ†ๆˆ–CVไธญใ€‚ๅœจ็คพไบคๅช’ไฝ“ๅ’Œ็ปฉๆ•ˆ่ฏ„ไผฐไธญๅˆ†ไบซๅฎƒใ€‚
SSB Logo

4.8
ๆ–ฐๆณจๅ†Œ
โ†’ ๆŸฅ็œ‹่ฏพ็จ‹